FDA Approved: IDOSE TR — Original Application (Glaukos Corporation)

View source ↗

Summary

The FDA approved IDOSE TR from Glaukos through an original NDA for travoprost delivered intracamerally to treat glaucoma by lowering intraocular pressure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma

Drugs mentioned

• IDOSE TR (travoprost intracameral)

Snippet

ORIG AP for IDOSE TR (TRAVOPROST INTRACAMERAL)